Implementing Dyadic Developmental Psychotherapy (DDP) - Evaluation Research
Launched by SYKEHUSET TELEMARK · Feb 18, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Children who have been subject to physical, sexual or emotional abuse or neglect are at risk of developing unhealthy relationships with their caregiver, increasing the likelihood of them developing a wide range of mental health problems later in life. Norway offers few therapeutic programs for treatment of children and adolescents that focus specifically on treating traumatic experiences within attachment relationships. An intervention with this focus is Dyadic Developmental Psychotherapy (DDP),where dyad refers to the unit of a child and its caregiver(s).
The Family-Based Treatment Unit (...
Gender
ALL
Eligibility criteria
- Inclusion criteria for child:
- • 1. Symptoms of relational and/or attachment difficulties
- • 2. History of trauma, including neglect or emotional abuse
- • 3. Age 5-18
- • 4. Can understand and make oneself understood in Norwegian
- Exclusion criteria for dyad (caregiver and child):
- • 1. Current substance abuse in child or caregiver
- • 2. Current psychosis in child or caregiver
- • 3. Intellectual disability in caregiver Variables that will be tracked but that are not grounds for exclusion are diagnostic variables, including the presence of autism-spectrum disorders, and care-level.
- Inclusion criteria for therapists:
- • 1. Trained in DDP
- • 2. Working with DDP in either of the centra
About Sykehuset Telemark
Sykehuset Telemark is a leading healthcare institution located in Norway, dedicated to providing high-quality medical care and advancing clinical research. As a clinical trial sponsor, Sykehuset Telemark is committed to enhancing patient outcomes through innovative studies and collaborations with various research partners. The hospital leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical trials across diverse therapeutic areas, ensuring adherence to ethical standards and regulatory compliance. By fostering a culture of research and education, Sykehuset Telemark aims to contribute to the development of new treatments and improve healthcare practices for the benefit of patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Skien, Vestfold Og Telemark, Norway
Patients applied
Trial Officials
Idun Røseth, Ph.D
Principal Investigator
Telemark Hospital Trust - University of South-East Norway
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials